Iododiflunisal (IDIF), a potent TTR stabilizer, was administered to AD mice and bound plasma TTR displacing T4, resulting in decreased Aβ amyloid burden and total Aβ brain levels, and improved cognition [40]. Here, TTR is linked to Alzheimer disease.